Mangalam Drugs and Organics Ltd

NSE: MANGALAM · BSE: 532637 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹33.09
Market cap: ₹52.38 Cr
Revenue (annual): ₹232.1 Cr
Net profit (annual): ₹-44.40 Cr
P/E (TTM): -1.4×Sector 47.3×
Promoter holding: 35.65%+0.00% QoQ
FII holding: 0.11%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Share Pledge 5 Other Announcement 5 Debt & Borrowing 5 Management Change 4 Financial Results 3 Board Meeting Date 3 Annual General Meeting 3 Legal & Regulatory 2 Adverse Business Impact 2 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

16 May 2026 15:33 IST NSE

Adverse Business Impact

Mangalam Drugs and Organics Adverse Business Impact

Mangalam Drugs and Organics reported a ₹15.58 Crore bank default. The company has submitted a restructuring proposal to lenders to address the situation.

Value: ₹15.58 Cr

Read the filing ↗

16 Apr 2026 17:27 IST BSE

Adverse Business Impact

Mangalam Drugs and Organics Adverse Business Impact

Mangalam Drugs and Organics Limited reported a combined default of ₹15.58 Crore on cash credit facilities from Bank of Maharashtra and Bank of Baroda. The defaults began in October 2025. The company stated it is making arrangements to pay the overdue amounts as soon as possible.

Value: ₹15.58 Cr

Read the filing ↗